New SEC Form D filing

Cellphire, Inc., 2026-11-16

A new SEC Form D private-offering notice from Rockville, MD, a $8,000,000 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

Cellphire, Inc. site↗ Verified via SEC Form D

Develops platelet based therapeutics, including cryopreserved and freeze dried platelet products, for bleeding and hemorrhage treatment

Filed 3 days agoFiled to raise $8,000,000First money in 2026-10-30Raised so far $6,494,308HQ (as filed) Rockville, MDSector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Call-ready
Source linked the Form D on EDGAR↗Website verified cellphire.com↗Named in the filing 7 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source